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Summary
Antibodies producing an unusual immunofluorescent pattern were identified in the sera ofpatients
with diverse autoimmune features. This pattern was characterized by the presence of up to six
round discrete nuclear bodies in interphase cell nuclei. Immunoblotting analysis showed that
these sera recognized an 80-kD nuclear protein, and affinity-purified anti-p80 antibody from
the protein band reproduced the fluorescent staining of nuclear bodies. Colloidal gold
immunoelectron microscopy showed that the affinity-purified anti-p80 antibody recognized the
coiled body, an ultramicroscopic nuclear structure probably first described by the Spanish cytologist
Ramon y Cajal. Five cDNA clones were isolated from a MOLT -4 cell Xgt-11 expression library
using human antibody and oligonucleotide probes. The longest cDNA insert was 2.1 kb and
had an open reading frame of 405 amino acids. A clone encoding a 14-kD COOH-terminal
region of the protein was used for expression of a O-galactosidase fusion protein. An epitope
was present in this COOH-terminal 14-kD region, which was recognized by 18 of 20 sera with
anti-p80 reactivity, and affinity-purified antibody from the recombinant protein also reacted in
immunofluorescence to show specific staining of the coiled body. This is the first demonstration
and molecular cloning of a protein that appears to have particular identification with the coiled
body, and it was designated p80-coilin. Autoantibody to p80-coilin maybe useful for the elucidation
of the structure and function of the coiled body, and the availability of a cDNA sequence could
be helpful in further studies to clarify the clinical significance of this autoantibody response.
T
he presence ofantibodies specifically directed against self
nuclear constituents in the serum ofpatients with con-
nective tissue diseases is a well known and extensively studied
phenomenon (for review, see reference 1). Some of these au-
toantibodies, such as anti-Sm and anti-native DNA, are dis-
ease restricted and have become useful clinical markers, since
they are found almost exclusively in systemic lupus ery-
thematosus. Most autoantibodies in systemic rheumatic dis-
eases have not been shown to be directly involved in disease
pathogenesis. However, anti-DNA and anti-SS-A/Ro autoan-
tibodies are examples ofpathogenic antibodies that may play
significant roles in lupus nephritis and neonatal lupus ery-
thematosus, respectively.
Antinuclear autoantibodies (ANA)' have also been potent
reagents in the elucidation of the nature and function ofnu-
clearproteins and subcellular structures. Several autoantibodies
' Abbreviations used in this paper., ANA, antinuclear antibodies; IIF, indirect
immunofluorescence; IPM, isopropyl-o-thiogalactopyranoside; KM, Kern-
Matrix; VLS, variable large speckles.
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are known to recognize specific cellular organelles, such as
the kinetochore/centromere (2), mitotic spindles (3), and cen-
trosomes (4) . Antibody probes can be used to further charac-
terize these structures and to screen cDNA libraries in order
to determine the primary sequence of their target antigens.
Autoantibodies were useful in the characterization ofthe struc-
ture and function of small nuclear ribonucleoprotein parti-
cles (5), in the cloning of the centromere antigen CENP-B
(6), and several proteins associated with small nuclear RNAs
(7-16).
This study reports on a novel human autoantibody that
was used to characterize a specific nuclear domain known
as the coiled body, an ultramicroscopic nuclear structure whose
nature and function are still unknown. The target autoan-
tigen was identified as an 80-kD protein, which we named
p80-coilin. Electron microscopic studies using anti-p80-coilin
antibodies suggested that the antigen is localized predomi-
nantly in the coiled body. Molecular information on the na-
ture ofthe 80-kD autoantigen was also provided by the cloning
of a partial cDNA sequence.
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Patients and Sera .
￿
Sera were collected either from patients seen
at Scripps Clinic andResearch Foundation or from patients referred
to our laboratory forANA testing . In all cases the diagnoses were
based on the review of clinical charts or information from the at-
tending physician. Normal sera were collected from laboratory per-
sonnel . The initial criterion for the selection of sera was based on
a characteristic immunofluorescent pattern that consisted ofup to
six discrete nuclear dots per interphase cell nucleus . This pattern
was clearly distinguishable from the speckled nuclear staining pro-
ducedby antibodies to ribonucleoprotein peptides such as Sm and
SS-B/La or from the more numerous dot pattern of antibodies to
kinetochore/centromere . Sera characterized immunologically and
clinically in previous studies (1, 2, 13, 16) andknown to contain
antibodies to other nuclear antigens were used in ELISA to estab-
lish specificity and prevalence .
Cell Extracts.
￿
All cell lines were obtained from the American
Type Culture Collection (Rockville,MD). HumanHeLa, MOLT4,
WI38, HEp-2, HepG-2, mouse3T3, and marsupialPtK2 cells were
cultured inDMEM containing10%FCSand2.5 ug/ml gentamicin
sulfate at 37°C and 8% C02. Cells were harvested and were ei-
ther solubilized immediately in Laemmli sample buffer (17) or ex-
tracted with buffer A, B, or C. Extractions were carried out at
4°C for 30 min with either low ionic strength buffer A (150 mM
NaCl, 10mM Tris-HCI,pH 7.2, 0.5% NP-40), high ionic strength
buffer B (500 mM NaCl, 50 mM Hepes, pH 7.0, 1% NP-40), or
triple detergent buffer C (150 mM NaCl, 50 mM Tris, pH 8.0,
0.1% SDS, 1.0% NP-40, 0.5% sodium deoxycholate). All extrac-
tion buffers contained the following protease inhibitors : 1 ug/ml
leupeptin, 1 pg/ml pepstatin, 2Ag/mlaprotinin (Sigma Chemical
Co ., St . Louis, MO), and 1mMPMSF (Calbiochem-BehringCorp.,
LaJolla, CA). After centrifugation at 12,000gfor 15 min, super-
natant andpellet were separately mixed with Laemmh sample buffer
to equal final volume.
Indirect Immunoiuorescence (IIF).
￿
UP cell substrate included com-
mercial HEp-2 cell slides (Bion, Park Ridge, IL), mouse
kidney/stomach slides (Kallestad Lab, Austin, TX), and slides pre-
pared from cell lines mentioned above. Cultures were grown to
subconfluencyon coverslipsin the conditions described above. Cells
were washed with PBS, pH 7.4, fixed in cold methanol (-20°C)
for 10 min, followed by cold acetone (-20°C) for 20 s, and air
dried . Autoimmune and control sera, as well as affinity-purified
antibodies, were diluted in PBS and used as primary reagent . The
secondary detecting reagentwas fluorescein-labeled goat antibody
to total human Ig, human IgG, or IgM heavy chain (Tago Inc.,
Burlingame, CA).
For extraction and digestion procedures, subconfluent Hela cells
grown on coverslips were washed for 10 min on ice with Kern-
Matrix (KM) buffer (10mM N-morphohnoethanesulfonic acid,pH
6.3, 10 mM NaCl, 1.5mM MgC12 , 10% glycerol ; reference 18) .
This buffer appeared to prevent detachment of the cells from the
coverslips during successive incubations and washings (18) . Cells
were permeabilized with 0.1% TritonX in KM buffer on ice for
10 min twice and then washed with KM buffer on ice five times
for a total of 20 min . Cells were then incubated with one of the
following solutions : (a) 50 Pg/mlDNase I (BoehringerMannheim
Biochemicals, GmbH ., FRG) in KM buffer at 37°C for 30 min ;
(b) 5 ug/mlRNaseA(Sigma Chemical Co .) in 10 mM phosphate,
pH 7.3, 3 mM MgC12, 100mM NaCI at 37°C for 30 min ; (c)
0.5, 1.0, or 2.0M urea in KM buffer at room temperature for 30
min; (d) 0.5, 1.0, or 2.0M NaCl in KM buffer at room tempera-
ture for 30 min ; (e) 0.5 Wg/ml proteinase K (Boehringer Mann-
heim Biochemicals) inKM buffer at room temperature for 10 min .
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Control cells were incubated with KM buffer alone at 37°C for
30min . These stepswere carried out with gentle shaking . Except
for proteinase K digestion, all other solutions were supplemented
with protease inhibitors, to the same concentrations as described
for the extraction buffers above .
Electron Microscopy.
￿
For conventional electron microscopy, cul-
tured cells were fixed in 2% glutaraldehyde in 0.1 M cacodylate
buffer for 1 h at 4°C, post-fixed in 1% osmium tetroxide for 1 h,
and embedded in epon . Thin sections were stained with uranyl
acetate and lead citrate . Forimmunoelectron microscopy, cells were
processed according to Reimer et al. (19). Briefly, cells were fixed
with paraformaldehyde, infused with sucrose, frozen, andcut . Thin
sections were incubated for30 min with primary antibody diluted
in PBS . Afterwashing with PBS, the sections were incubated with
10nm gold particle-labeled goat anti-human IgGandIgMOanssen
Pharmaceutica, Beerse, Belgium) for 25 min, washed in PBS, and
post-embedded in methylcellulose.
Immunoblotting .
￿
Cell extracts were separated in SDS-PAGE using
12.5% gel slabs (15 x 10 x 0.1 cm) according to Laemmli (17) .
Separated proteins were electrotransferred to nitrocellulose at acon-
stant voltage of 60 V for 150 min at 8°C . Nitrocellulose sheets
were cut into strips, blocked in 3% nonfat milk in PBS containing
0.05% Tween 20 (PBST) for 30 min, and then exposed for 1 h
to serum diluted 100-fold in the same blocking solution . After ex-
tensive washing with PBS-T, bound antibody was detected with
[""I]-labeled protein A (ICN Biochemicals, Irvine, CA) followed
by autoradiography at -70°C . Protein standards for molecular
weight determination were obtained either from Bio-Rad Labora-
tories, Richmond, CA, or from Bethesda Research Laboratories,
Gaithersburg, MD.
Isolation ofcDNA Clones.
￿
Ahumanleukemia T cell (MOLT-4)
Xgt11 cDNA library was constructed by Drs . K. Ogata andD . J .
Noonan (Scripps Clinics and Research Foundation) . 10 6 recom-
binants were screened with a high titer serum Sh and [MI]-labeled
protein Aaccording to Young and Davis (20) . All screenings were
carried out with duplicate filters . One positive clone X213 was
selected after multiple re-screening and was grown in EschericW
coli LE 392 for phageDNA isolation . ThecDNA insert released
by digestion with EcoRI was 1.25 kb and was subdoned into
plasmid Bluescript (Stratagene, LaJolla, CA) . Theplasmid obtained,
designated pGR14, was used for large-scaleDNApreparation and
sequence determination by thedideoxymethod (21) . Overlapping
restriction fragments were subdoned into plasmid Bluescript for
determination of DNA sequence in both strands.
To obtain longer cDNA clones, the same cDNA library was
re-screened by DNA hybridization using als1p]-labeled synthetic
oligonucleotides . Two partiallycomplementary synthetic oligonu-
cleotides (TCTGTTACCACTGTTAGCAGCTGCCCCTCA and
TCTTTTCTCCAACTTGAGGGGCAGC'PGCTA) were designed
corresponding to the 5' sequence ofpGR14 cDNA insert . They
were mixed and labeled with a['2P]-ATP using the standard fill-
in reaction of Klenow polymerase (22) .
Affinity Purification ofAntibodies.
￿
Affinity purification of anti-
bodies from nitrocellulose-bound antigen wasperformed according
to themethod of Olmsted (23) . Theantigen source was either the
80-kD band from HeLa cell extract resolved by SDS-PAGE and
transferred to nitrocellulose, orcDNAencoded antigenfrom X213
lysogen adsorbed onto nitrocellulose filters. The expression of the
X213 recombinant antigen was induced with isopropyl-is-thio-
galactopyranoside (IPPG ; Sigma Chemical Co., St . Louis, MO).
Afterblocking with3% nonfat milk inPBST for30 min, nitrocel-
lulose filters were incubated for 1 h with serum diluted 1:50 in
the same blocking buffer. Bound antibodies were eluted by briefincubation with 0.1M phosphate buffer, pH 2.5, in 0.1% BSA,
150 mM NaCl . The eluted antibody was immediately neutralized
by addition of1M Tris-HCl,pH 8.8, and concentrated with Cen-
tricon 30 microconcentrators (Amicon, Danvers, MA), and tested
in IIF and immunoblotting.
Purification ofRecombinant Protein .
￿
Plasmid pGR14 was used
forcDNA expression ofp80-coffin as aS-galactosidase fusion pro-
tein . A 200-ml culture of the recombinant cells was grown to
ODwo = 0.6 at 37°C, andWW was added to a final concentra-
tion of 10 mM . The culture was further grown overnight at 37°C
before harvest. The inclusion bodies were purified according to the
method of Adam et al . (24). Aliquots of the supernatant in the
final 8M urea extraction of the inclusion bodies were stored at
-70°C and subsequently used for ELISA and immunoblotting.
ELISA . Standard ELISA was performed according to the
method described by Rubin (25) . Immulon 2 microtiterplates (Dy-
natech Laboratories, Inc., Alexandria, VA) were coated overnight
at 4°C with serial dilutions of the purified recombinant protein
in PBS with 1 hg/ml leupeptin. The detecting reagents were
peroxidase-conjugated goat anti-human IgG+M (Caltag Labora-
tories, So . San Francisco, CA) and the substrate 2,2'-azinobis
(3-ethylbenzthiazoline sulfonic acid) (Boebringer Mannheim Bio-
chemicals) .
Results
Characterization of Patients and Sera .
￿
From a total of 25
sera defined to contain antibodies reacting with the special
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nuclear structures described below, 21 were identified on the
basis of the immunofluorescent pattern, and four additional
serawere later detectedby screening inELISA with therecom-
binant protein (see below) . Clinical data were available for
20 patients, 16 ofwhom were female ; themean age was 40.4
yr, ranging from 15 to 70 yr. Table 1 depicts the principal
clinicalfeatures as well as the titerofthe nuclear body staining
and ofother immunofluorescent patterns. Although the clin-
ical diagnoses appearedto behighlydiverse, the majority could
be grouped into certain categories . There were threepatients
with primary biliary cirrhosis, 12 patients with some form
ofrheumatic disease, such as Sjogren's syndrome (including
Tt who also had PBC), scleroderma, and systemic lupus
erythematosus, and threepatients with neurological involve-
ment . It needs to be stated that the clinical information was
inadequate and was obtained from retrospective chart review
or personal information from physicians, and the complete-
ness of the clinical data is uncertain . In all sera, the im-
munofluorescent staining of nuclear bodies was found to be
due to IgG antibodies. No precipitin line on standard Ouchter-
lony immunodiffusion was observed when tested against rabbit
thymus extract .
IndirectImmunofuorescent Detection ofAutoantibodies to Nu-
clear Bodies. All sera shared a distinct immunofluorescent
pattern, consisting of bright, discrete dots distributed in in-
terphase nuclei (Fig. 1), which from observations described
' Concomitant staining patterns: CS, cytoplasmic speckles; NH, nucleoplasmic homogeneous; NS, nucleoplasmic fine speckles .
t Sera identified by ELISA screening (see also Table 3) .
Table 1 . Clinical and Serological Synopsis of Patients with Antibodies to p80-coilin
Patient Sex Age Clinical presentation
Nuclear body
UP titer
Concomitant IIF Pattern*
and titer
Tk M 40 Primary biliary cirrhosis 1 :40,960 CS/1 :5,120
Kmt F 70 Primary biliary cirrhosis 1:1,280 CS/1:320
TO F 55 Primary biliary cirrhosis and Sjogren's syndrome 1:10,240 CS/1:2,560
Abt F 33 Primary Sjogren's syndrome 1 :1,280 NS/1 :1,280
Gm# M 42 Primary Sjogren's syndrome 1 :10,240 NS/1 :2,560
Sf F 45 Progressive systemic sclerosis 1:20,480 CS/1:640
Pz F 31 Systemic lupus erythematosus 1:640 NH/1 :640
Wo F 47 Raynaud's phenomenon 1 :640 NH/1 :160
Mo F 16 Dermatomyositis 1 :640 NS/1 :1,280
Nu F 68 Polymyalgia rheumatica 1:5,120 NH/1 :640
Tu F 27 Skin rashes/arthralgia 1:640 NH/1 :160
El F 59 Osteoarthritis/fibromyalgia 1 :640 NS/1 :160
Wi F 60 Osteoarthritis 1 :160 NS/1 :160
Bu F 63 Soft tissue rheumatism 1 :1,280 NH/1 :160
Wk F 47 Amyotrophic lateral sclerosis 1:2,560 NH/1 :640
Cl F 24 Sixth nerve palsy/photosensitivity 1 :1,280 NH/1 :640
Pk F 15 Severe right brachial plexopathy 1 :1,280 NH/1 :640
Du F 30 Hashimoto's disease 1 :640 NH/1 :640
Sh M 20 Respiratory infection/rash 1:2,560 NH/1 :320
Op M 16 Cold urticaria 1 :10,240 NS/1 :640Figure 1 .
￿
Immunofluorescent pattern characteristic of antibodies to nuclear coiled bodies. Commercial HEp-2 cells were stained by different selected
human sera. (A) serum Sh; (B) serum Tk; and (c) serum Nu. Discrete round bodies were stained in the nucleoplasm of interphase cells . Most sera
showed an additional fine grainy nucleoplasmic staining. In B, a speckled cytoplasmic staining was also observed .
below will be called nuclear bodies . The number of stained
nuclear bodies varied from zero to six per cell, the most fre-
quent being two per cell (Fig. 2) . Although most nuclear
bodies were located randomly in the nucleoplasm, they were
often seen in close proximity to the nucleolus . At low dilu-
tion, all sera presented other concomitant fluorescent staining
patterns, such as homogeneous nuclear, fine speckled nucleo-
plasmic, or cytoplasmic speckled patterns, which disappeared
at higher dilutions (see Table 1) . These concomitant staining
patterns were probably related to the presence of other au-
toantibodies, but partially because of their lower titers and
heterogeneity, this feature was not further examined .
The nuclear bodies were observed in IIF on a number of
human substrates (peripheral lymphocytes, HEp-2, HepG-2,
WI38, HeLa, andMOLT-4 cell lines), mouse tissues (brain, liver,
kidney, stomach, and smooth muscle), and marsupial PtK2
cells . The range in the number of nuclear bodies and their
sizes appeared to be the same among these substrates, except
for a lower frequency of nuclear bodies in PtK2 cells .
To obtain some insights into the nature of the target an-
tigen, HeLa cells were subjected to treatment with various
reagents before standard immunofluorescence . The staining
ofnuclear bodies with human autoantibodies was not altered
when the substrate was pre-treated with either 2 M NaCl,
2M urea, or 0.1 N HCI . Staining was completely abolished
after digestion with proteinase K and barely visible after diges-
tion with RNase A, but was unaffected withDNase I . These
observations suggested that the antigen recognized by human
autoantibodies was a protein and it could be complexed in
some form with RNA .
Immunoblotting Analysis.
￿
Sera selected on the basis of the
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characteristic immunofluorescent pattern showed common
reactivity with an 80-kD protein in Western blotting with
HeLa whole cell extract (Fig. 3 A) . Other bands were ob-
served in some lanes but they were not uniformly present .
Affinity-purified antibodies from the 80-kD band did not cross-
react with other protein bands (Fig . 3A, lane 8) . The affinity-
purified antibody preparations were also shown to reproduce
the characteristic nuclear staining pattern, providing further
% of Cells
3 4 5 6
Number of Nuclear Bodies/Cell
Figure 2 .
￿
Distribution of cells withdifferent number ofnuclearbodies.
The frequency ofnuclear bodies percell was determined by immunofluores-
cence using Hep-2 cell substrate. The curve represented the average, and
the bar at each data point represented the range for three sera, Wo, Op,
and Sh . 200 cells were analyzed for each serum.Figure 3 .
￿
Immunoblottinganalysis.
(A) HeLa whole-cellextract resolved in
12.5% SDS gel electrophoresis was used
as a substrateforimmunoblotting . Lane
1, prototype human anti-Ku serum AF
showing strong reactivity at 70 and 82
kD (left border arrours); lanes 2-5 and 7,
sera from patients Tk, Sh, Pk, Du, and
Op, respectively, recognizing a common
protein of80 kD (right borderarrow); lane
6, normal human serum; lane 8, anti-
bodies from serum Op affinity purified
from the 80-kD band . The affinity-
purified antibodies in lane 8 did not
show reactivity with other protein
bands . (B) In an attempt to solubilize
the 80-kD antigen, MOLT-4 cells were
extracted and fractionated as described
in Materials and Methods using either
high ionic strength buffer B or triple
detergent bufferC. The fractions were
separated in a 12.5% gel and transferred
to nitrocellulose, which was probed
with serum Nu diluted 1:100 . Lane 1,
whole cell extract; lanes 2 and 3, in-
soluble and soluble fractions, respec-
tively, after extraction with triple de-
tergent buffer C; the bulk of 80-kD
proteinwas present inthe insoluble frac-
tion and only traces were detected in
the soluble fraction ; lanes 4 and 5, insoluble and soluble fractions, respectively, after extraction with high ionic strength buffer B, when approximately
halfof the 80-kD protein was present in the soluble fraction . Other bands displayed by serum Nu are given by unrelated antibodies andbehave differently
from the 80-kD band .
evidence of the association of the 80-kD band with the IIF
pattern (Fig . 4) .
WhenMOLT -4 cells were extracted with low ionic strength
buffer A before solubilization in Laemmli buffer, the bulk
o£ the 80-kD reactivity remained in the nuclear, insoluble
fraction (data not shown) . Even the triple detergent buffer
C did not extract the 80-kD protein . However,when harsher
conditions of extraction were used, as with high ionic strength
Figure 4 . IIF staining using affinity-purified antibody to the 80-kD protein . HEp-2 cells were stained with serum Op (A), antibody from serum
Op affinity purified from the 80-kD band (B, same antibody preparation as used in Fig. 3 A, lane 8), and normal human serum (C) . The affinity-purified
antibody preparation recognized the characteristic nuclear bodies with slight nucleoplasmic background staining .
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Immunolocalization of nuclear bodies in electron microscopy. Conventional epon section of a Hela cell. Acoiled body (large arrows) and
a simple nuclearbody (small arrow) are present in the nucleoplasm . N, Nucleolus (06,800) . The inset shows the immunolocalization of a coiled body
(arrows) in a cryosection of a Heia cell using human antibodies affinity purified from the 80-kD protein and 10 nm gold particles conjugated to goat
anti-human IgG and IgM . The localization of gold particles was restricted to the coiled body (x90,000).
pGR14 1.25kb
pJEL3 1.35kb
pJEL2 1.8kb
pCOIL1 2.lkb
pJELI 2.lkb
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Figure 6.
￿
Schesnaticrepresentation ofcDNA clonesde-
rived fromtheMOMlibrary.Open boxes represent the
open reading frameand heavy lines represent the 3' un-
translated regions. Partial nucleotide sequencing showed
identity among overlappingregions ofthe fiveclones . Thin
and thick arrows representDNAsequences derived from
restriction fragment subcloning and sequencingwith syn-
thetic oligonucleotide primers, respectively. Restriction
enzyme sites R, P, andHare EcoRl, Pstl, and HindIII,
respectively.buffer B, which contains 0.5 M NaCl, the antigen appeared
to be equally distributed between the soluble and insoluble
fractions (Fig . 3 B) .
Immunoelectron Microscopy.
￿
Using an electron microscopic
technique in which ultra-thin sections ofHeLa cells were first
incubated with whole serum or affinity-purified antibodies
and then with 10 nm gold-labeled detecting reagent, it was
possible to define the ultrastructure of the nuclear bodies.
The gold particles were strikingly enriched in round bodies
of 0.5-0.8 Ftm in diameter, which correspond to what has
beep described as the coiled body (26-28) . Fig. 5 shows a
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HeLa cell nucleus, depicting three morphologically distinct
structures : the nucleolus, a simple nuclear body, and a coiled
body . The latter structure possesses certain distinctive aspects
consisting of high density meandering threads of 30-60 nm
in cross-section interspersed with areas of density similar to
the rest of the nucleoplasm . The coiled body has been de-
scribed in the interchromatin space, usually in no more than
one per ultra-thin section . The inset of Fig. 5 shows a coiled
body stained with antibodies affinity purified from the 80-
kD band. In all sections examined, the coiled bodies were
positively labeled, suggesting that this antigen is a constant
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GAAAGTGACTATAACCCAAACTTTTTTTTTTTTTAAAGAGGATTTGGAAGTTGTATGGATTTTTTTGTTATCTTCACTTTACTGCATAGG
AAACAATCTACCTCATCATTTAAAATGACATGGGTGTCGGTTTTGTAGATCTTTGGTTTTTTTGTCAGGTTTAATTACCATTAACAAATG
TAAAACATGACATTCCCTGCAGATATTGTTGTATACCAGTATGGTTTATTATCTTTCTTTAAATCTTATTGGCCATCAAGTATGCAGTCG
TCAGTATGTGATGTTTATAATACCAATGAATGTGCTGCGTATCTTGTCTCAATAAGTTTTAAGTAACATTTAAAAATATTAAAGCATGTT
ATTTGACCTAATTTTTTAGCATTTGAGTTGTTCCATTAAATGGAGCATCTTGTAAATTTCAAGTATTTTATACTTGCAATTGTTAAGAGT
TAACAGGTAGTTGGATTTGTCGCAGACAATGAGTTAAGGAATCCTTTCACGTTTTTCCCAACTTTAAAATTAAGGATTCTCAGGTCCCTG
TGTAGAGCAGTGAAAATAAGATGTGCGTATGTGTGTGTATGCCTGGAGATTGGTGTTTCACTTCAGTGAGAGGATTGGCTGTGAGCTTCA
GACCAGAAATGTGTCATCTTGCCAGCCCCTGGCTGAGTGTGCTGGAGTGAGGATCTTGAACAGAAACTTCCTTTTCTGTTATTATTCACT
ACGAAGCTAAAATGGCCAAATATATACCGTGAAAATTGGTTTCATTTAACAAAAGATCAGATCCCTCCTTCAGCTGTACACATTTTTAAA
TAAAATCATATTGAACT-2088 poly-A
Figure 7 .
￿
Nucleotide sequence and deduced amino acid sequence of p80-coilin. Nucleotide sequence of 2,088 bases was derived from analysis of
the overlapping cDNA clones outlined in Fig . 6. Shown below theDNA sequence is the deduced protein sequence, representing 405 amino acids
ofp80-coilin with a predicted molecular mass of43kD. Ser- and Thr-rich regions (boxed areas) and Lys- and Arg-rich regions (underscored) ofp80-coilin
sequence are indicated. The predicted polypeptide has relatively high percent of Ser (15.3%) and basic amino acid residues (Arg + Lys + His =
15.3%) . The pl estimated by the ISOELECTRIC program (49) is 9.72 . The occurrence ofshort peptide repeats AIa-Arg-Asn-Ser and Ser-Leu-Pro-Ala
and the four direct repeats of Arg-Gly are underscored by two lines. The significance of the amino acid repeats is not known. The sequence data
are available from EMBL/Genbank/DDBJ under accession number M58411.
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sistent accumulation of the gold-labeled probe was observed
elsewhere in the nucleus or cytoplasm . Accordingly, this 80-
kD antigen was provisionally designated p80-coilin.
Cloning ofp80-coilin cDNA .
￿
Fig. 6 depicts the cDNA
clones obtained from aMOLT4 411 expression library . After
screening 106 recombinant colonies with serum Sh, clone
X213 was obtained and subcloned into plasmid Bluescript as
pGR14 . Clones JEL1, JEL2, and JEL3 were obtained from
screening another lot of 106 recombinant colonies from the
same library, using synthetic oligonucleotides corresponding
to the 5' end of the cDNA insert ofpGR14 . Clone COIL1
was obtained from a third round of screening of the MOLT-4
library using synthetic oligonucleotides corresponding to the
5' region of JELL cDNA insert . COIL1 cDNA was in fact
30 nucleotides shorter than that ofJELL . The overlapping
regions ofthese clones were identical. The longest cloneJELL
had an open reading frame of1,215 nucleotides, which would
encode a polypeptide with a predicted molecular mass of 43
M The partial cDNA sequence for p80-coilin antigen and
the deduced amino acid sequence are shown in Fig. 7 . No
consensus sequence motif orhomology with other published
sequences was identified. Special features of the amino acid
sequence include a high percentage of serine (15 .3%), the
presence of short peptide repeats (Ala-Arg-Asn-Ser and Ser-
Leu-Pro-Ala), and four direct repeats of Arg-Gly. In an at-
tempt to obtain full-length cDNA, three other libraries de-
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Figure 8 . Immunoblotting analysis of
recombinant protein derived from X213 .
Immunological relatedness between the
X213 recombinant protein and . p80-coilin
was examined byWestern blotting. Extracts
were resolved on SDS-PAGE using 12.5%
separating gels and transferred to nitrocel-
lulose filters. Individual strips wereprobed
with sera or affinity-purified antibody. (A)
Reactivity of affinity-purified antibody in
MOLT -4 whole cell extract . IPIG-induced
plaques of phage X213 were adsorbed to
nitrocellulose filters and were used for the
affinity purification ofantibody from serum
Sh . Lane 1, affinity-purified antibody from
serum Sh ; lane2, serum Sh . (B) Reactivity
ofhuman sera to bacteria lysate expressing
the recombinant protein of X213. Lane 1,
normal human serum; lane 2, serum with
antibodies toSm/RNP and SSA/SS-B ; lane
3, serum with antibody to Ku and
ribosomalRNP ; lane 4, serum with anti-
body to Scl-70 andPCNA; lanes 5-11, seven
anti-p80-coilin sera, Sh, Pk, Nu, Bu, Tu,
Du, and Ve, respectively. The 130-kDband
blotted in common by anti-p80-coilin sera
represented the fusion protein of 0-galac-
tosidase and the 14-kD fragment of p80-
coilin encoded in X213 . The 130-kD band
was not recognized by normal human
serum or other autoirnmune antibodies .
rived from HL60, HepG2, and WI38 cells were analyzed .
After screening 106 phages from each library, we obtained
clones that confirmed the sequence obtained from theMOLT -4
library, but did not uncover the lacking 5' sequence.
A recombinant protein was obtained from clone X213 by
inducing the expression of the phage lac gene withIPTG. This
fusion protein contains the deduced 14-kDCOOH-terminal
region of p80-coilin . Affinity-purified antibody was able to
reproduce both the 80-kD band in Western blotting (Fig.
8A) and the IIF nuclear body staining pattern (Fig. 9) . The
homogeneous nucleoplasmic staining observed with the
original serum (Fig. 9 A) was not detected by antibodies
affinity purified from the recombinant protein (Fig . 9 B) .
A lysate ofE . coli expressing the recombinant protein from
X213 was used as substrate for immunoblotting with different
sera (Fig . 8 B) . The reactivity with the 130-kD (0-galac-
tosidase--p80-coilin fusion protein) was observed in 18 of 20
serawith anti-p80-coilin specificity, and not detected by normal
human serum or sera with other known autoantibody speci-
ficities. Such a specific reactivity with most of the prototype
sera suggests that at least oneimmunodominant autoepitope
is present in the COON-terminal region ofthe molecule rep-
resented by clone X213.
A purified preparation of the recombinant protein derived
from pGR14 (the same cDNA fragment in X213, subcloned
into plasmid Bluescript) was used to coat microtiter plates
for ELISA . Fig . 10 shows the titration curves of the antigenFigure 9.
￿
IIF staining using amity-purified antibody from recombinant protein encoded by phage X213 . HEp-2 cells were immunostained either
with serum Sh (A) or amity-purified antibody, the same preparation as in Fig. 8 A, lane 1 (B) . The characteristic staining of nuclear coiled bodies
wasexhibited byboth preparations, but theweak nucleoplasmic stainingexhibited by the whole serum was not detected with the affinity-purified antibody.
against three prototype anti-p80-coilin sera and a normal
human serum . Table 2 depicts the ELISA readings obtained
with normalhumansera, different autoimmune sera, and anti-
p80-coilin sera after 1 h ofincubation with the detecting re-
agents, confirming the sensitivity and specificity ofthe assay.
This ELISA system was used to screen sera from several
different diseases (Table 3) . Sera with OD41o reading three
times above the normal range were further screenedby Western
blotting and HE None of the patients with rheumatoid ar-
thritis, chronic active hepatitis, multiple sclerosis, scleroderma,
or systemic lupus erythematosus were found to have anti-
bodies to p80-coilin . 2 of 59 sera from primary biliary cir-
rhosis (3.4%) and 2 of 54 sera from primary Sjogren's syn-
6,000
￿
1a,ooo
￿
1:4.000
￿
1:2.000
￿
1:1,000
￿
drome (3.7%) contained antibodies to p80-coilin .
dilution of the recombinant protein
O.D.410nm
8
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Figure 10 .
￿
ELISA reactivity of the recombinant protein derived from
pGR-14.A partiallypurifiedpreparation ofrecombinantpGR14was pre-
pared as described in Materials and Methods, diluted from 1:1,000 to
1:16,000, and used to coat microtiter wells. Titration curves for the recom-
binant protein were obtained with three prototype anti-p80-coilin sera and
a normal human serum all used at 1:200 dilutions .
Discussion
The coiled body is a nuclear ultrastructure defined as round-
to-oval bodies averaging 0.5-0.8 j,m in diameter, composed
ofcoiled and fibrillar strands. It is located in the interchromatin
space at various distances between the nucleolus and the nu-Recombinant protein substrate was used at the dilution of 1:8,000 (see
Fig . 10) . All sera were diluted 1:200 . ELISA ODayo readings were 1 h
after addition of detecting reagent .
clear envelope . It was first described at the light microscopic
level in 1903, by the Spanish cytologist Ramon y Cajal (26) .
Using special silver staining techniques, Cajal detected heavily
stained inclusions in nuclei of neurons and designated them
"accessory bodies". The ultrastructural identity of bodies
defined as the coiled body and the accessory body of Cajal
was suggested by Hardin et al . (29) and confirmed by Seite
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Sera abovewerefirst screened by ELISA against the recombinant protein
derived from pGR14 . Those with OD,io three times above the normal
range were further tested and confirmed by immunofluorescence and
Western blotting . Those sera identified on basis of immunofluorescence
alone (see also Table 1) are not included .
et al . (30), and Lafarga et al. (27) . The coiledbody is a highly
conserved cell component, being observed in several eukary-
otic cells (31), and although it has been the subject ofmany
morphological studies, no major insight into its function has
been achieved .
Human sera with a distinct immunofluorescent pattern,
consisting ofdiscrete round intranuclear bodies, were shown
to recognize a cellular protein with an electrophoretic mo-
bility of 80 kD in Western blotting. This association was
confirmed by the reproduction of the nuclear body staining
pattern using antibodies affinity purified from the 80-kD band.
By immunoelectron microscopy, the antigen was shown to
be predominantly located in the coiled body, thus being desig-
nated p80-coilin . Human autoantibodies to p80-coilin and
synthetic oligonudeotides were used asprobes to isolatecDNA
clones. The recombinant protein X213 representing a 14-kD
region from theCOOH terminus was recognized by most
ofthe prototype anti-p80-coilin sera in Western blotting and
in ELISA, suggesting that at least one epitope is present at
the COON-terminal end of the molecule .
The literature on indirect immunofluorescence ofantinuclear
antibodies describes a variety of nuclear speckled patterns.
The IIF pattern observed with anti-p80-coilin antibody, which
will be called nuclear coilin pattern, consisted ofdiscrete round
bodies randomly distributed in the interphase nucleoplasm,
ranging from zero to six per cell . Characteristically, these
nuclear bodies were not evident in the metaphase plate of
mitotic cells . The nuclear coilin pattern can be easily distin-
guished from the one related to anticentromere antibodies,
since the latter presents a higher number and smaller size
of speckles and a characteristic distribution at the metaphase
plate (2) . Another readily distinguishable imrnunofluorescent
pattern is the one called variable large speckles (VLS), which
is represented by 3-10 nuclear dots of variable size, and is
caused by antihistone H3 antibodies (32) . In contrast to the
nuclear coilin pattern, VLS staining is primarily observed in
tissue substrates and not detected in lymphocytes and cul-
tured cells (32) .
Table 3. Antibodies to P80-coilin
Disease
Rheumatoid arthritis
Patients
tested
31
Positive
patients
0
Scleroderma 44 0
Systemic lupus erythematosus 44 0
Sjogren's syndrome 54 2
Primary biliary cirrhosis 59 2
Chronic active hepatitis 32 0
Multiple sclerosis 26 0
Table 2. Reactivity
Sera
of Recombinant Protein
Patient
pGR-14 in ELISA
Reactivity
Normal human RU 0.002
Sa 0.006
Pe 0.045
La 0.029
To 0.012
Autoimmune Anti-dsDNA 0.010
Anti-ssDNA 0.016
Anti-Sm 0.000
Anti-SSA/SSB 0.004
Anti-Ku 0.004
Anti-p80-coilin MO 0.220
Tu 0.261
Wi 0.293
El 0.381
St 0.401
Pz 0.402
CI 0.407
Du 0.407
Wk 0.465
Ve 0.481
Wo 0.490
Bu 0.500
Ab 0.574
Km 0.630
Nu 0.649
Cq 0.670
Pk 0.758
Sh 0.768
Op 0.872
KI 1 .405
Sf 1.526
Tt 1 .607
Gm 1 .666
Kr 2.419
Tk 3.108Reports of discrete speckled nuclear IIF patterns are found
in the literature under various designations, such as "mul-
tiple nuclear dots" (33-35), "atypical discrete speckled nu-
clear staining" (36), "nuclear dots" (33, 37), and "NSpI" (nu-
dear speckled I) (38) . Since these studies did not provide further
characterization of the target antigens, it is not possible to
make retrospective comparisons with p80-coilin. By means
of an exchange of sera with Dr. M . J . Fritzler (Calgary,
Canada), it was possible to rule out the identity of "NSpI"
and coiled bodies . Recently, a patient with a paraneoplastic
syndrome resembling systemic lupus erythematosus was
reported to have serum antibodies reacting with three bands
X80kD in Western blotting and also yielding an immuno-
fluorescent pattern of two to three nuclear dots (39) . It is
conceivable that one of the antigens targeted by this serum
was p80-coilin, although other autoantibodies may yield a
similar IIF pattern .
The biochemical composition and function of the coiled
body are largely unknown since heretofore it hasbeen identified
only by light and electron microscopy. In preliminary studies
in this laboratory, we have used immunoelectron microscopy
and double label immunofluorescence, with anti-p80-coilin
as the reference marker and other specific antinuclear anti-
bodies as detecting reagents, in order to determine which
nuclear antigens of known structure and function might
colocalize with p80-coilin . The most striking finding was
the close association of p80-coilin with fibrillarin, a 34-kD
protein component of the U3 ribonucleoprotein particle (40),
which has been shown to be involved in 5' ribosomal RNA
processing (41) . Also identified in the coiled body were Sm
and U1 RNP antigens and m3G capped small RNA, all of
which are components of small nuclear ribonucleoproteins
involved in pre-mRNA splicing (42, 43) . The presence of
Sm antigens in the coiled body had also been demonstrated
previously (44, 45) . These preliminary findings might sug-
gest a role for the coiled body in splicing or otherRNA pro-
cessing functions, but further studies need to be performed .
Also of interest are some electron microscopic studies that
suggest a relationship between the coiled body and the
nucleolus (29, 30) . Recently, we were able to obtain some
evidence supporting these observations (46) . Using double
immunofluorescencewithhuman autoantibodies to p80-coilin
and mouse mAb to fibrillarin (40), we showed that in rat
neurons the coiled body is frequently in close association with
the nucleolus . Furthermore, when HeLa cells were treated
with actinomycin D or 5,6-dichloro-1-R-D-ribofuranosyl-
benzimidazole, agents that promote nucleolar segregation into
granular and fibrillar components, p80-coilin immunostaining
was detectable in the fibrillarin-positive regions of the segre-
gated nucleoli (46) . Although the sensitivity of p80-coilin
immunofluorescence to RNase might suggest an association
of the protein with RNA, the sequence of the partialcDNA
for p80-coilin did not exhibit any of the traditional RNA
recognition motifs (14, 47) . However, it shouldbe noted that
in the primary structure of the available sequence, there are
two stretches rich in basic amino acids arginine and lysine
that could be involved inRNA binding (reviewed in refer-
ence 48) .
Autoantibodies to p80-coilin were not associated with a
single disease entity but were detected in diverse disease con-
ditions. In spite of this apparent diversity, 12 of 20 patients,
inwhom clinical information was available, fell into the broad
category ofrheumatic diseases, including Sj6gren's syndrome,
systemic lupus erythematosus, scleroderma, and Raynaud's
phenomenon, as well as other rheumatic diseases usually
thought to be nonautoimmune in nature. The apparent as-
sociation with rheumatic diseases, however, may need to be
taken with reservation since this study was initiated from
the observation of an unusual signal inANA immunofluores-
cence and it is highly likely that the patients from which
these sera were derived were being seen predominantly in
rheumatology clinics . Although not extensive, analysis in
ELISA using recombinant p80-coilin (Table 3) showed that
the antibody was detected in a few patients with Sjogren's
syndrome and primary biliary cirrhosis . It is intriguing to
consider the possibility that this autoimmune response might
be related to some special clinical feature in diverse diseases,
but at the present time, the limited clinical information and
retrospective nature of the study have not helped in providing
any leading clues to this question . It is possible that prospec-
tive studies and analysis of other diseases might be more re-
vealing. At the present time, the identification of a distinc-
tive antibody marker for the nuclear coiled body and the
availability ofcDNA clones encoding a related protein com-
ponent might be of help in elucidating the function of this
nuclear organelle .
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